Informazioni
Dr. Ali Chamseddine is a Consultant Medical Oncologist from France, holding dual board certifications in medical oncology and clinical haematology, as well as MD and PhD degrees. He gained expertise at the esteemed Gustave Roussy Cancer Center in Villejuif, France, where he served as a senior medical oncology consultant. Dr. Chamseddine further honed his skills through a post-doctoral fellowship at the Division of Cancer Medicine, Leukaemia Department, at the renowned MD Anderson Cancer Center in Houston, Texas, USA.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Ali Chamseddine
Istruzione e formazione
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Oncologia
Carriera e incarichi
-
2017-09–2018-08 Junior consultant
Licenze e assicurazione
Licenze mediche
AE — Organización Médica Colegial de España (OMC)
Certificazioni di specializzazione
European Board of Oncologia
Assicurazione responsabilità professionale:
Allianz Professional · 5,000,000 EUR copertura · No claims on file
Procedure eseguite
| Procedura | Codice | Conteggio totale |
|---|---|---|
| GP consultation | 99213 | 130 |
| Annual physical exam | 99395 | 2,884 |
| Vaccination administration | 90471 | 1,828 |
| Minor procedure (skin) | 17110 | 1,267 |
Servizi e prezzi
| Servizio | Durata | Modalità | Prezzo |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 360.00 EUR |
Studio, team e in pratica
Video
Ricerca e pubblicazioni
indice h: 11 · i10: 3
-
Validation of clinical scoring in Oncologia
DOI: 10.7129/euroclin.2026.0 · PMID: 37579667 · citato da 130
-
Long-term follow-up of Oncologia across AE
DOI: 10.5594/euroclin.2025.1 · PMID: 31987343 · citato da 200
-
Validation of clinical scoring in Oncologia
DOI: 10.6633/euroclin.2024.2 · PMID: 37865520 · citato da 118
Conferenze su invito
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Dubai · 2023 · oral abstract
Premi e affiliazioni
Premi
- 🏆 Top-rated Oncologia — Dubai · EuroClinics Patient Choice · 2025 · regional
Iscrizioni a società
- WONCA Europe — Family Doctors — Member · Dal 2018
- national college of family doctors — Member · Dal 2018
- European Union of Medical Specialists (UEMS) — Member · Dal 2018
Articoli di questo medico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Per pazienti internazionali
- Coordinatore
- Patient liaison · ali.chamseddine@euroclinics.example
Posizione
1 tagRecensioni dei pazienti
Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
Recensioni recenti
-
★★★★★ ✓ Verificato Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificato Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificato Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
